|
* The ATP III panel did not find adequate evidence to recommend routine measurement of insulin resistance (e.g., plasma insulin), proinflammatory state (e.g., high-sensitivity C-reactive protein), or prothrombotic state (e.g., fibrinogen or PAI-1) in the diagnosis of the metabolic syndrome.
Some male persons can develop multiple metabolic risk factors when the
waist circumference is only marginally increased, e.g., 94-102 cm (37-39 in).
Such persons may have a strong genetic contribution to insulin resistance.
They should benefit from changes in life habits, similarly to men with
categorical increases in waist circumference.